Cardiovascular events are not significantly decreased with edetate disodium chelation in patients with CAD and history of myocardial infarction and diabetes.

Rising Pharma Holdings, Inc., d/b/a Rising Pharmaceuticals, Inc. (“Rising”) announced commercial availability of Edetate calcium disodium injection. Access to Rising’s product continues despite a ...

The study, published in JAMA, revealed that EDTA-based chelation decreased median blood lead levels by 61% from baseline in patients with diabetes and prior MI, however, it failed to reduce major ...

Also, the chelation therapy involved not just the chelating agent disodium EDTA, but also high-dose vitamin C, magnesium, the anesthetic procaine and the blood thinner heparin. There was a high ...

This week's topics include tranexamic acid for liver resection, edetate disodium (EDTA)-based chelation therapy, suicidality among spouses of people with cancer, and do amino acids protect kidneys ...

In 2013 the findings surprised the academic world when those in the EDTA chelation arm of the trial were found to have lower rates of cardiovascular events than those in the placebo group. Eleven ...

The trial involves the intravenous (IV) administration of the chelating agent disodium ethylene-diamine-tetra-acetic acid (EDTA), for which there was a brief enthusiasm among academics during the ...